XRP price holds key support, bottom signals emerge for rebound

XRP has begun to display multiple bottom signals after defending a short-term support band, prompting traders to monitor whether a trend reversal is underway. Cointelegraph reporting notes that XRP/USD remains above the $1.25–$1.30 zone, a level that has repeatedly attracted buying interest in recent sessions.

On-chain and technical metrics underpin the cautious optimism. TradingView data shows the XRP/BTC relative strength index (RSI) sitting at 24, the most oversold reading since October 2025, while the MVRV Z-score is hovering near zero—historically levels associated with accumulation and market troughs. Glassnode cost-basis heatmaps indicate roughly 1.73 billion XRP were acquired around the current price area, reinforcing the presence of a meaningful demand pool.

As long as the $1.25–$1.30 support holds, short-term recovery scenarios remain plausible. Analysts referenced in the report point to a potential bounce toward $1.45 and highlight a longer-range upside near the $1.61–$1.70 area if buying interest sustains. Conversely, a breakdown below the next defensive line at roughly $1.15—where the 200-week simple moving average sits—could open a measured bear-flag target near $0.80 and materially increase downside pressure.

The episode fits into a broader pattern in which similar on-chain and technical alignments have preceded sizeable XRP recoveries. Past instances cited in the coverage include multi-month rallies following comparable metric setups, underscoring that these indicators can signal genuine inflection points. Nonetheless, macro liquidity conditions and broader crypto market sentiment will modulate any rally’s breadth and duration.

Market participants and analysts emphasize confirmation from price action before committing to directional views. Some traders on social platforms expect a short-term rebound if the $1.25–$1.30 zone holds, while risk-focused strategists advise close monitoring of volume and support integrity to avoid false breakouts. As always, positions should be sized with disciplined risk management and independent research in mind.